Work

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Year: 2015

Type: article

Study design: Observational Study

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2015.07.010

Authors: Chung-Han Lee, Andreas M. Hötker, Martin H. Voss, Darren R. Feldman, Kaitlin M. Woo, Sujata Patil, Devyn T. Coskey, Oguz Akin, James J. Hsieh, Robert J. Motzer

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, Merck, Memorial Sloan-Kettering Cancer Center, Genentech, National Cancer Institute

Award: Cancer Center Support Grant

OpenAlex ID: W1052483428

FWCI: 0.475

Cites: 18

Cited by: 10

Related to: 10